Highlights d TNF-a induces TMPRSS2-ERG gene fusion formation in androgen-responsive cells d DNA damage by oxidative stress mediates TNF-a-induced gene fusion formation d Androgen signaling is required for TNF-a-induced TMPRSS2-ERG gene fusion formation d The non-homologous end-joining (NHEJ) pathway is associated with genomic rearrangements
INTRODUCTION
There is considerable evidence for the role of inflammation in the development of several forms of human cancer (Balkwill and Mantovani, 2001; Coussens and Werb, 2002; Grivennikov et al., 2010) ; however, the mechanistic details are not clear. Prostate cancer in particular has been associated with proliferative inflammatory atrophy (PIA), a putative precursor lesion indicative of an inflammatory etiology (De Marzo et al., 1999 . In terms of recurrent driver mutations, approximately 50% of prostate cancers are associated with gene fusions of the androgen-regulated gene TMPRSS2 to the oncogenic erythroblast transformation-specific (ETS) transcription factor ERG . Androgen signaling induces spatial proximity between the TMPRSS2 and the ERG gene loci, which in combination with gamma irradiationinduced DNA breaks, facilitates the formation of gene fusions Mani et al., 2009) . That said, the in vivo mechanisms contributing to DNA breaks that underlie the formation of TMPRSS2-ERG are far from clear. Here, we explore the hypothesis that inflammation plays a key role in the genesis of prostate cancer by promoting the formation of recurrent gene rearrangements.
RESULTS

Inflammation Induces TMPRSS2-ERG Gene Fusion Formation
The cytokine, tumor necrosis factor alpha (TNF-a), plays a central role in orchestrating the inflammatory response (Baud and Karin, 2001) . To initially recapitulate the effects of inflammation in vitro, we stimulated the TMPRSS2-ERG gene fusion-negative LNCaP prostate cancer cells with TNF-a for 48 hr. To our surprise, we observed robust formation of the TMPRSS2-ERG gene fusion transcript by TNF-a stimulation, as assessed by TaqMan-based qRT-PCR and gel-based . Gene fusion formation induced by TNF-a was equal to, or more efficient than, exposure to 5 and 50 Gy irradiation ( Figure S1A ), which we and others have reported on (Haffner et al., 2010; Lin et al., 2009; Mani et al., 2009) . This was particularly exciting in that the prostate gland is more likely to be exposed to pro-inflammatory stimuli than to large doses of gamma radiation, making inflammation a more physiologic inducer of gene fusions. The short timescale of these experiments and the observation that stimulation with TNF-a does not increase the levels of TMPRSS2-ERG or total ERG transcripts in VCaP cells, which endogenously harbor the TMPRSS2-ERG gene fusion , indicate that the observed effects are not due to selective growth or survival conferred by the treatment or due to an increase in transcript levels from a fixed population of cells with rearrangements already present ( Figure S1B ). We therefore report the genesis of gene fusions in the absence of clonal selection. On the basis of standard curve analysis of serially diluted VCaP cells, we estimate the induced TMPRSS2-ERG rearrangement frequency in LNCaP cells to be about one event in 10,000 cells ( Figure S1C ). Sequence analysis of the TNF-a-induced fusion transcripts in LNCaP cells revealed joining of the first exon of TMPRSS2 with exon 4 of ERG, which is the most common TMPRSS2-ERG isoform in prostate cancers and is also endogenously present in VCaP prostate cancer cells ( Figure 1C ) .
We next examined the role of androgen signaling in TNFa-mediated TMPRSS2-ERG gene fusion formation. Depletion of androgens from the media or androgen receptor (AR) knockdown by small interfering RNA (siRNA) blocks TMPRSS2-ERG gene fusion formation upon TNF-a stimulation (Figures 1D and 1E) . In addition to LNCaP cells, we observe TNFa-induced TMPRSS2-ERG gene fusion formation in LAPC-4 (F) Induction of TMPRSS2-ERG gene fusion transcripts in the AR-positive cell line, LAPC-4, upon stimulation with TNF-a (100 ng/mL for 48 hr), but not in the AR-negative cell line, DU145. TaqMan qRT-PCR analysis of the TMPRSS2-ERG fusion transcript in LAPC-4 or DU145 cells treated with PBS (n = 5) is compared to TNF-a treatment (n = 5; *p < 0.01 by two-tailed Mann-Whitney U-test). Each data point represents the mean of two technical replicates from an independent treatment. See also Figure S1 . cells that are androgen sensitive. However, the androgen-insensitive DU145 cells are resistant to TNF-a-induced gene fusion formation (Figures 1F and S1D) . Stimulation of LNCaP cells with TNF-a does not result in detectable levels of TMPRSS2-ETV1 gene fusion or BCR-ABL1 gene fusion, products of inter-chromosomal rearrangement observed in <5% of prostate cancers (Tomlins et al., 2007) or in most chronic myelogenous leukemia (CML) cases (Rowley, 1973) respectively ( Figure S1E ). Collectively, these results indicate that (1) genomic rearrangements are non-random, cell-type-specific events dictated by lineage-restricted cell signaling pathways (e.g., androgen signaling in prostate cancer), and (2) intra-chromosomal rearrangements (e.g., TMPRSS2-ERG) are more prevalent than inter-chromosomal rearrangements. 
Inflammation Induces DNA Double-Strand Breaks and De Novo Genomic Rearrangements
To demonstrate that DNA damage occurs upon exposure of LNCaP cells to TNF-a, we monitored phosphorylated histone H2A.X (Ser139), which was elevated within 12 hr of exposure ( Figure S2A ) and was recruited to known translocation sites at TMPRSS2 and ERG loci ( Figure S2B ). Stimulation of LNCaP with TNF-a resulted in RAD51 foci formation, indicating initiation of DNA repair function ( Figure 2A ). Furthermore, by employing a split-signal-based dual-color fluorescence in situ hybridization (FISH) assay, we observed breaks in the TMPRSS2 and ERG loci upon stimulation of LNCaP cells with TNF-a ( Figures 2B and 2C ). Gamma radiation (5 and 50 Gy), as previously shown Mani et al., 2009) , induced breaks in these loci and was included as a positive control. We observed that TMPRSS2 is more prone to DNA breaks in comparison to ERG. Because TMPRSS2 is transcriptionally active before the formation of gene fusions, and ERG is not, we speculate that the frequency of DNA breaks at a locus is correlated with its transcriptional activity.
We developed a custom capture sequencing pipeline to study inflammation-induced de novo genomic rearrangements at the single-molecule level in the absence of clonal selection. We designed probes to capture TMPRSS2, ERG, and a few control loci (e.g., MIPOL1 and DGKB), followed by deep sequencing (>2,0003 depth) and analysis. To benchmark our analysis pipeline, we characterized the genomic breakpoints associated with MIPOL1-DGKB gene fusion, a clonal rearrangement in LNCaP cells, characterized by two cryptic insertions of a minimal region around ETV1 (chromosome 7) into the MIPOL1 gene (chromosome 14) (Maher et al., 2009; Tomlins et al., 2007) . We rediscovered the known genomic breakpoint between MIPOL1 and DGKB and also identified a novel second genomic breakpoint between the two genes ( Figure S3A ). Both breakpoints are associated with junction microhomologies of four and two nucleotides, respectively ( Figure S3B ).
Next, we de-convoluted the genomic rearrangements associated with TMPRSS2-ERG gene fusion in VCaP cells. We rediscovered the four reported breakpoints (Teles Alves et al., 2013; Weier et al., 2013) , including an inter-chromosomal rearrangement ( Figures S3C and S3D ). Two of the four breakpoints exhibited blunt junctions; the remaining two breakpoints displayed, respectively, a single nucleotide junction microhomology and an eight-nucleotide ''non-templated'' insertion that could not be aligned to either of the contributing loci ( Figure S3E ). Sanger sequencing analysis confirmed a complex genomic rearrangement involving the sense strand of TMPRSS2 intron 1, the antisense strand of TMPRSS2 intron 5, and the sense strand of ERG intron 3 as the genomic event contributing to the TMPRSS2-ERG gene fusion ( Figure S4 ).
We applied this analysis pipeline to study LNCaP cells treated with PBS or TNF-a. We observed robust formation of de novo genomic rearrangements upon TNF-a stimulation ( Figure 2D ). Because the short experimental time frame precludes clonal selection, all discovered rearrangements represent single-molecule events. Our stringent algorithm selected only those rearrangements that were supported by junction spanning reads, thereby facilitating detailed analysis of junction characteristics and repair mechanisms.
Because homologous recombination (HR) has been suggested to maintain genome integrity by blocking genomic rearrangements (Moynahan and Jasin, 2010), we tested the effect of a defective HR by simultaneous knockdown of ATM, BRCA1, and RAD51, key players in the HR pathway ( Figure S5 ). Due to the functional redundancy among the major HR players, we hypothesized that silencing multiple HR components will significantly inhibit the HR pathway. We observed that a defective HR, in the absence of an external stress, is relatively inefficient in the formation of genomic rearrangements. A combination of TNF-a stimulation and HR deficiency further increased the formation of de novo genomic rearrangements ( Figure 2D ). The generally low frequency of the specific genomic rearrangement between TMPRSS2 and ERG genes, due to the absence of clonal selection, precluded us from identifying DNA rearrangement junctions between these two genes. Hence, we focused on identifying the general principles underlying TNF-a-induced DNA rearrangements involving TMPRSS2 or ERG rather than DNA rearrangements between TMPRSS2 and ERG genes.
DNA Sequence and Epigenetic Features of TNFa-Induced De Novo Genomic Rearrangements
About 75% (19/25) of the induced de novo genomic rearrangement breakpoints exhibit junction microhomology ranging from one to six nucleotides ( Figures 3A-3F and S6A ). The observed breakpoints exhibited an average microhomology length of 1.84 bp, significantly longer than the average length obtained from 10,000 simulated sets of randomly generated breakpoints (p < 0.0001) ( Figure 3G ). Two of the six blunt junctions exhibit microhomology on the reverse strand, a previously undescribed phenomenon. We speculate that reverse microhomology may facilitate genomic rearrangements by a mechanism involving transient base pairing ( Figure S6B ). The de novo DNA rearrangements induced by inflammation have characteristics observed in cancer-associated translocations, because a study reported 1 to 4 bp microhomology in most translocation junctions in prostate cancer specimens (Weier et al., 2013) . Altogether, these characteristics of the induced breakpoint junctions implicate microhomology-mediated non-homologous end-joining (NHEJ) as the pathway associated with de novo genomic rearrangements.
The recurrently fused intron 3 of ERG is 130 kb long and is one of the largest introns in the human genome ( Figure 3H ). We hypothesized that the DNA sequence and epigenetic features afforded by the large intron size could dictate the formation of TNF-a-induced breaks in a transcription-independent manner. We queried the induced de novo breakpoints against DNA sequence features like non-B DNA structures (inverted repeats, mirror repeats, direct repeats, G-quadruplex-forming repeats, Z-DNA repeats, A-phased repeats, and short tandem repeats). None of these features demonstrated significant enrichment near the observed breakpoints. Upon ruling out DNA sequence elements, we analyzed epigenetic features by querying datasets generated by the Encyclopedia of DNA Elements (ENCODE) project (Consortium et al., 2012; Thurman et al., 2012) . A significant fraction of the genomic breakpoints identified in ERG lay within DNase I hypersensitivity sites (DHSs) (43.75%, p < 0.0001); the genomic breakpoints in TMPRSS2 were not significantly enriched in DHSs ( Figure 3I ). This result suggests that DNase I hypersensitivity, and by extension open chromatin, may contribute to the formation of some genomic breaks in ERG. We conclude that breaks in TMPRSS2 are dictated by its transcriptional status and breaks in ERG by epigenetic features like DHSs.
Oxidative Stress as the Mediator of Inflammation-Induced Gene Fusion Formation TNF-a stimulation has been reported to increase reactive oxygen species (ROS) production via multiple mechanisms (Blaser et al., 2016; Chandel et al., 2001; Kim et al., 2007 Kim et al., , 2010 Yazdanpanah et al., 2009) . We hypothesized that oxidative stress-mediated DNA damage may be the underlying mechanism for the generation of DNA double-strand breaks required for gene fusion formation. Stimulation of LNCaP cells with TNF-a resulted in a dose-dependent increase in ROS production ( Figure 4A ). Consistent with earlier studies (Kim et al., 2010) , we observed that treatment with cycloheximide (CHX), an inhibitor of protein biosynthesis, enhanced TNF-a-induced ROS production (Figure 4A) . This is presumably due to CHX-induced blockade of nuclear factor kB (NF-kB)-mediated antioxidant production. TNF-a-induced ROS production can be reversed upon treatment with the ROS scavenger N-acetylcysteine (NAC) ( Figure 4A ). TNF-a-induced ROS production and DNA damage were also observed in the androgen-sensitive LAPC-4 cells, androgeninsensitive DU145 cells, and benign immortalized non-transformed RWPE-1 cells (Figures 4B and 4C) . Thus, we conclude that androgen signaling is not required for TNF-a-mediated formation of DNA breaks. Rather, AR redirects ROS-mediated DNA damage to the TMPRSS2 locus by enhancing transcription, opening up the DNA, and thereby making it susceptible to DNA double-strand breaks. TNF-a-induced DNA breaks in the ERG locus are likely to be AR independent. This set the stage for the next set of experiments to test the role of oxidative stress in gene fusion formation.
The Role of ROS in ETS Gene Fusion Formation
Although single-agent treatment of LNCaP cells with either TNF-a or CHX induced DNA damage, a combination of TNF-a and CHX markedly enhanced the extent of the DNA damage, as visualized (A-F) TNF-a-induced de novo chromosomal translocations are associated with junction microhomologies. The 25 observed genomic breakpoints were compared with distributions of randomly simulated breakpoints (10,000 sets of 25 breakpoints) for six measures of junction microhomology. A significantly greater fraction of the observed breakpoints exhibited junction microhomology than expected by chance, for any length up to six bases. Of the observed breaks, 76% have 1 bp or more of junction microhomology (p = 0.0002) (A), 52% have 2 bp or more (p = 0.0001) (B), 28% have 3 bp or more (p = 0.0003) (C), 16% have 4 bp or more (p = 0.0012) (D), 8% have 5 bp or more (p = 0.0093) (E), and 4% have 6 bp or more (p = 0.0482) (F). (G) The 25 observed genomic breakpoints were compared with distributions of randomly simulated breakpoints (10,000 sets of 25 breakpoints) for junction microhomology length. The observed breakpoints exhibited an average microhomology length of 1.84 bp, significantly longer than expected by chance (p < 0.0001). (H) ERG's recurrently fused intron is among the largest in the genome. Protein-coding genes in chromosomes 1-22, X, and Y were selected from the Ensembl gene reference, and the longest transcript was taken as representative of each gene. Intron sizes were interpolated from transcript exon boundaries and then sorted and plotted as shown. ERG's recurrently fused intron is 130,040 bases long and is thus larger than 99.49% of annotated introns. TMPRSS2's recurrently fused intron is 9,891 bases long and is thus larger than 87.54% of annotated introns. (I) Association between ERG genomic breakpoints and DNase I hypersensitivity sites (DHSs). DHS peak data were acquired from the ENCODE data portal and filtered for sites identified in greater than 10% of the 125 cell lines profiled. The observed induced genomic breakpoints within ERG and TMPRSS2 were then compared with distributions of randomly simulated breakpoints (10,000 sets of 16 and 10,000 sets of 4). A significantly greater fraction of the genomic breakpoints identified in ERG lay within DHSs than expected from the random distribution (43.75%; p < 0.0001) (left). The genomic breakpoints in TMPRSS2 were not significantly enriched in DHSs (right). See also Figure S6. by phosphorylated histone H2A.X (Ser139) western blotting (Figure 5A) . Consistent with this observation, the combination of TNF-a and CHX significantly increased TMPRSS2-ERG gene fusion formation in comparison to single-agent treatments (Figure 5B) . TNF-a-induced TMPRSS2-ERG formation was blocked by treatment with NAC ( Figure 5B ). Thus, ROS is the mediator of TNF-a-induced TMPRSS2-ERG gene fusion formation. To recapitulate the effect of TNF-a-induced ROS formation, we treated LNCaP cells with H 2 O 2 . Treatment with H 2 O 2 resulted in a dose-dependent increase in DNA breaks and TMPRSS2-ERG gene fusion formation ( Figures 5C and 5D ). The induction of TMPRSS2-ERG gene fusion with H 2 O 2 was orders of magnitude higher than stimulation with TNF-a alone. H 2 O 2 treatment also induced the formation of the inter-chromosomal TMPRSS2-ETV1 rearrangement, although the frequency was very low (Figures 5E and 5F ). However, we did not observe H 2 O 2 -induced formation BCR-ABL1 rearrangement in LNCaP cells, although BCR and ABL1 genes are expressed in these cells ( Figure S7A) . These results provide further support to the conclusion that gene fusions originate in a non-random, cell-type-dependent manner.
Air-Pouch Model of Inflammation to Study Gene Fusions
Next, we explored whether gene fusions can be induced by inflammation in an in vivo setting. To do this, we took advantage of a well-studied murine model of in vivo inflammation, which occurs in an artificial air pouch (Edwards et al., 1981) . The air pouch Figure S7. is generated by the injection of sterile air under the dorsal skin of mice. Injection of an inflammatory irritant (e.g., lipopolysaccharides [LPS]) into the air pouch produces an inflammatory response that is characterized by the infiltration of inflammatory cells and the production of cytokines or chemokines (Romano et al., 1997) . We injected 10 million LNCaP cells in control or LPS-treated air pouches raised in the immunodeficient severe combined immunodeficiency (SCID) mice or immunocompetent C57BL/6 mice ( Figure 6A ). The cells were recovered 24 hr postinjection by air-pouch lavage. We did not observe TMPRSS2-ERG gene fusion transcripts in LNCaP cells recovered from the air pouches of SCID mice with or without LPS treatment. By contrast, TMPRSS2-ERG gene fusions were observed in LNCaP cells injected into the air pouch of C57BL/6 mice, the levels of which were further accentuated upon treatment with LPS (Figure 6B) . These results suggest that analogous to our in vitro data, inflammation in vivo induces the formation of TMPRSS2-ERG gene fusions. We next optimized the split-signal-based dual-color FISH assay with TMPRSS2 and ERG probes on LNCaP cells derived from the murine air pouch. These probes are human specific and do not cross-react with mouse cells (Figure S7B) . Split-signal dual-color FISH assays revealed breaks in the TMPRSS2 and ERG locus of LNCaP cells derived from C57BL/6 mice, but not SCID mice ( Figures 6C and S7C) .
Because LPS was injected in the air pouch 1 day before cell implantation, a direct effect of LPS on LNCaP cells can be ruled out. Furthermore, because LPS-treated air pouches in the SCID mouse background did not induce the formation of gene fusions, we conclude that the observed effects are a consequence of host inflammation. In concordance with our previous results using TNF-a and gamma irradiation, the frequencies of inflammation-induced in vivo breaks were higher at the TMPRSS2 locus compared to the ERG locus. This suggests that DNA breaks in ERG are a rate-limiting step in the formation of TMPRSS2-ERG gene fusions. Because the air pouch is a model of tissue injury, and human LNCaP cells are recognized as a foreign graft in C57BL/6 mice, there is substantial inflammation that adversely affects cell viability, given that the cells stay in the pouch for 24 hr. Due to the emerging role of macrophages in tumor development (Qian and Pollard, 2010) , we tested their role in LPS-mediated TMPRSS2-ERG gene fusion formation in the C57BL/6 mouse air-pouch model. We employed a liposome-based approach to deplete phagocytic cells (macrophages or neutrophils) from C57BL/6 mouse air pouches by injecting Clodrosome (in which clodronate is encapsulated in the aqueous compartment of the liposomes) or Encapsome, the vehicle control (Van Rooijen and Sanders, 1994; Zeisberger et al., 2006) . The liposomes are not taken up by non-phagocytic cells; unencapsulated clodronate cannot cross the cell membrane to initiate cell death. Macrophage depletion was evaluated by immunofluorescence using the F4/80 monoclonal antibody that recognizes a macrophage-restricted cell surface glycoprotein ( Figure 6D ). Macrophage depletion resulted in a reduction in the total cellular infiltrate in the air pouch, suggesting impaired recruitment of other immune cells to the air pouch ( Figure 6E ).
We measured TMPRSS2-ERG gene fusion formation in LNCaP cells injected into LPS-stimulated C57BL/6 mouse air pouches with Encapsome treatment and compared this against treatment with Clodrosome (macrophage-depleted setting). While the Encapsome-treated group exhibited robust formation of TMPRSS2-ERG gene fusion, the effect was blocked in the Clodrosome-treated group ( Figure 6F) . These data clearly indicate a role for macrophages or neutrophils in TMPRSS2-ERG gene fusion formation. Because SCID mice contain macrophages, we conclude that macrophages are necessary, but not sufficient, for in vivo gene fusion formation. Our data suggest that a complex network of interactions between macrophages and other immune cell types (B and T cells) mediate gene fusion formation. Reports indicate a role for bromodomain and extrater-minal domain (BET) protein inhibitors like JQ1 and I-BET in suppressing inflammation (Belkina et al., 2013; Nicodeme et al., 2010) . BET inhibition has been shown to decrease proinflammatory cytokine production in macrophages and ablate inflammatory responses in mouse models. We observe that treatment with JQ1 blocks TMPRSS2-ERG gene fusion formation in the air-pouch model for in vivo inflammation ( Figure 6G ). Because JQ1 also blocks AR function (Asangani et al., 2014) , it is conceivable that the observed effects are due to a combined suppression of inflammation and androgen signaling. We thereby present definitive evidence for the role of inflammation in gene fusion formation.
DISCUSSION
Altogether, these results implicate a critical role for inflammation-induced oxidative stress in the formation of DNA breaks leading to recurrent gene rearrangements in prostate cancer. Although other potential mechanisms of DNA breaks exist, we suspect that inflammation-induced oxidative stress may be a significant contributor of DNA damage. Endonucleases like RAG and AID have been implicated the formation of DNA breaks, resulting in genomic rearrangements involving the immunoglobulin loci. For example, the RAG complex and AID are involved in the formation of the follicular lymphoma-associated t(14;18) BCL2-IGH translocation and Burkitt's lymphoma-associated t(8;14) IGH-MYC translocations, respectively (Ramiro et al., 2004; Tsujimoto et al., 1985) . Because the expression levels of these endonucleases are very low or undetectable in the normal prostate or prostate cancers, these are unlikely to be physiologically relevant in the genesis of prostate cancer-associated genomic rearrangements. Although transcription can introduce breaks in 5 0 gene fusion partners that are highly expressed (e.g., TMPRSS2), most 3 0 partners such as ERG and ETV1 exhibit no or minimal transcription in the prostate gland before gene fusion formation (Haffner et al., 2010) . Thus, transcription alone cannot explain the formation of DNA breaks in both partner genes leading to ETS gene fusions. Genotoxic drugs (e.g., clastogens), chemotherapeutic drugs (e.g., cisplatin), topoisomerase inhibitors (e.g., camptothecin and etoposide), and other drugs such as hydroxyurea and aphidicolin can induce DNA double-strand breaks. ETS gene fusions are early events and arise in patients before they are treated with any of these drugs. Thus, exposure to such drugs may not contribute to DNA breaks leading to ETS gene fusions in prostate cancer. While DNA replication is considered a major source of DNA breaks, the prostate luminal cells, which are widely believed to be the cell of origin for prostate cancer, are post-mitotic cells. Neuroendocrine cells in the prostate lumen are also post-mitotic. The basal cells of the prostate have a very low mitotic index. Thus, cell division or DNA replication is not likely to be a major contributor to DNA breaks required for ETS gene fusion formation in the prostate. Although ionizing radiation is an excellent external source of DNA damage, the in vivo sources of DNA breaks that contribute to the formation of genomic rearrangements in prostate cancer are not well defined.
We suggest that inflammation-induced oxidative stress is a major source of DNA breaks in the human prostate. The upstream triggers for inflammation can be diet, lifestyle, infection, and even the normal process of aging. While the potential association between inflammation and prostate cancer is not new, there are few direct mechanistic links of inflammation to recurrent driver mutations in cancer. By building on earlier work on chromosomal proximity and DNA rearrangements (Baca et al., 2013; Berger et al., 2011) , our working model suggests that AR induces the proximity of genes such as TMPRSS2 and ERG Mani et al., 2009) , while inflammatory stimuli trigger DNA breaks via oxidative stress (Figure 7) . Our studies implicate microhomology-mediated NHEJ as the repair process contributing to inflammation-induced de novo genomic rearrangements. The strong association of PIA with human prostate cancer may represent circumstantial morphologic evidence for this link (De Marzo et al., 1999) . These studies suggest that anti-inflammatories may have a role in the chemoprevention of prostate cancer, as suggested by published epidemiological studies (De Marzo et al., 2007; Nelson et al., 2003; Sfanos and De Marzo, 2012) . Broadly, while these studies have been carried out in a prostate cancer model, the results suggest a potential role for inflammation-induced oxidative stress in the genesis of gene fusions across different cancer types.
EXPERIMENTAL PROCEDURES
Cell Culture, Transfection, Immunofluorescence, and Immunoblot Analysis LNCaP and DU145 cells were cultured in RPMI 1640 medium containing 10% fetal bovine serum (FBS) in a 5% CO 2 humidified incubator. LAPC-4 and VCaP cells were cultured in Iscove's modified Dulbecco's medium (IMDM) and DMEM, respectively, supplemented with 10% FBS.
For in vitro stimulation experiments, cells were treated with 100 ng/mL TNFa (Sigma) for various time intervals. For androgen depletion experiments, the cells were cultured in phenol-red free media containing 10% charcoal-stripped serum (HyClone) for 2 days.
Non-targeting siRNA (D-001810-10), AR siRNA (J-003400-08), ataxia telangiectasia mutated (ATM) siRNA (L-003201-00-0050), BRCA1 siRNA (L-003461-00-0050), and RAD51 siRNA (L-003530-00-0050) were obtained from Dharmacon. siRNA was transfected using Lipofectamine RNAiMAX transfection reagent (Invitrogen, #13778-150) according to the manufacturer's protocol.
For immunofluorescence analysis, cells were fixed in ice-cold methanol, followed by blocking, incubation with primary antibodies against RAD51 (Santa Cruz Biotechnology, #sc-8349), and detection with anti-rabbit secondary an-
ROS Assay
Intracellular ROS was detected by fluorescence-activated cell sorting (FACS) analysis of 60,000 LNCaP cells with various treatments using the Total Reactive Oxygen Species (ROS) Assay Kit 520 nm (eBioscience) according to the manufacturer's protocol.
ACCESSION NUMBERS
The accession number for the custom capture sequence data used to detect genomic breakpoints and reported in this paper ( Figures 2D and S3 
Induced Gene Fusion Formation in Prostate Cancer
Proliferative inflammatory atrophy (PIA) is associated with inflammatory cells that secrete pro-inflammatory cytokines (e.g., TNF-a). This results in the formation of ROS-induced DNA breaks, which in combination with androgen signaling-induced proximity between gene fusion partner loci, can facilitate ETS gene fusion formation, thereby promoting prostate cancer development. 
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